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ApoptosisThe Jun NH2-terminal kinase (JNK) which serves as an important component of cellular signal transduction
pathways has been shown to regulate many viral infections. The present study demonstrated for the ﬁrst
time that infectious bursal disease virus (IBDV), the causative agent of a highly contagious disease in
chickens, can activate JNK1/2 pathway in IBDV-infected cells dependent upon viral replication. IBDV-induced
JNK1/2 activation causes its downstream target c-Jun phosphorylation, which kinetically paralleled JNK1/2
activation. Investigations into the mechanism of JNK1/2 regulation revealed that inhibition of JNK1/2 activa-
tion leads to reduced viral progeny release, which is associated with decreased viral transcription and lower
virus protein expression, and thereby limiting apoptotic cell death as evidenced by blockage of Bax activation,
cytochrome c release, and caspase activation. These data suggest that the JNK pathway plays an important
role in the IBDV replication and contributes to virus-mediated changes in host cells.rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Infectious bursal disease virus (IBDV), from the genus Avibirnavirus
within the family Birnaviridae, is a non-enveloped, double-stranded
RNA virus consisting of two segments, segment A (3.2 kb) and B
(2.9 kb), encoding ﬁve proteins (Delmas et al., 2005; Mundt et al.,
1995). Infectious bursal disease, caused by IBDV, is an acute, highly con-
tagious and immunosuppressive disease in 3- to 15 week-old chickens,
resulting in great economic loss in the poultry industry (Lukert and
Saif, 1997). IBDV can be differentiated into two serotypes (I and II)
(McFerran et al., 1980). Serotype I strains show different degrees of
pathogenicity and mortality in chickens, whereas serotype II strains
are avirulent in chickens (Ismail et al., 1988; Lukert and Saif, 1997).
IBDV targets the precursors of antibody-producing B lymphocytes in
the bursa of Fabricius (BF), leading to lymphoid depletion of B cells
and the destruction of BF. Infection by this virus results in a severe im-
munosuppression in young chickens, inducing an increased susceptibil-
ity to other infectious diseases as well as poor immune response to
vaccines (Lukert and Saif, 1997; Van Den Berg, 2000).
The c-Jun NH2-terminal kinases (JNK), aswell as extracellular signal-
regulated kinases (ERK1/2) and p38 mitogen-activated protein kinases
(MAPK), are central components of signal transduction pathways in
the regulation of cell proliferation and differentiation, cytokine produc-
tion, apoptosis, and cell survival (Garrington and Johnson, 1999; Lamb
et al., 2003). Activated JNK can phosphorylate numerous substrates,including a variety of transcription factors such as c-Jun and ATF-2
(Derijard et al., 1994; Kyriakis et al., 1994). Phosphorylation and activa-
tion of these downstream substrates ultimately alters gene transcrip-
tion and expression, thereby manifesting the biological consequences
of JNK activation (Weitzman and Yaniv, 1998). Research data have
shown that many viruses such as human immunodeﬁciency virus
type 1 (HIV-1) (Kumar et al., 1998), echovirus 1 (Huttunen et al.,
1998), herpes simplex virus type 1 (HSV-1) (Zachos et al., 1999), Kaposi's
sarcoma-associated herpes virus (Pan et al., 2006; Xie et al., 2005), cox-
sackievirus B3 (Si et al., 2005), and varicella-zoster virus (Zapata et al.,
2007)manipulate the JNK signaling pathway to regulate viral replication
and gene expression. Also, the JNK pathway is involved in cell apoptotic
death induced by some viruses, including HSV-1 (Perkins et al., 2003),
coxsackievirus B3 (Kim et al., 2004), reovirus (Clarke et al., 2004),
swine inﬂuenza virus (Choi et al., 2006), and poliovirus (Autret et al.,
2007). IBDV infection has been demonstrated to induce apoptosis both
in vitro and in vivo (Lam, 1997; Ojeda et al., 1997; Tanimura and Sharma,
1998; Vasconcelos and Lam, 1994). Accumulating evidence demon-
strates that the IBDV-induced apoptosis is through release of cytochrome
c from the mitochondria to the cytosol thereby activating caspase-9 fol-
lowed by caspase-3 pathway (Liu and Vakharia, 2006; Liu et al., 2007).
Khatri and Sharma (2006) reported that IBDV used p38 MAPK signal
transduction machinery to elicit macrophage activation. However,
there is still no report on the activation of the JNK pathway induced
by IBDV replication and the effect of its activation on IBDV-induced
apoptosis.
This study was initiated to determine whether the JNK pathway
plays a role in the IBDV replication as well as IBDV-induced apoptosis.
Here, we report that phosphorylation of JNK1/2 is increased during
157L. Wei et al. / Virology 420 (2011) 156–163IBDV replication and demonstrate that activation of the JNK pathway
is essential for efﬁcient IBDV replication. Inhibition of JNK1/2 activa-
tion reduces viral mRNA transcription and protein synthesis, viral
progeny release, and IBDV-induced apoptotic responses as evidenced
by blockage of Bax activation, cytochrome c release, and caspase acti-
vation. These ﬁndings indicate that the JNK signaling pathway is in-
volved in the IBDV replication and contributes to virus-mediated
changes in host cells.
Results
IBDV activates the JNK signaling pathway dependent upon viral replication
We began by determining whether IBDV infection of DF-1 cells
resulted in JNK1/2 activation. Serum starved DF-1 cells were infected
with IBDV strain LM (Liu et al., 2002) at a multiplicity of infection
(MOI) of 10 TCID50 per cell. Incubation with PBS served as mock-
infected controls. Kinetics of JNK1/2 phosphorylation at Thr183/
Tyr185, which is required for full JNK activation, was investigated in
mock- and IBDV-infected cells. Whole-cell lysates were analyzed at
the indicated times postinfection by Western blotting with a speciﬁc
anti-phospho-JNK1/2 antibody. The amount of phosphorylated JNK1/2
was evident at 6 h, the maximal activation was seen at 24 h, and
reached a normal level at 48 h postinfection (Fig. 1A). The increasedA
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Fig. 1. IBDV activates JNK1/2 signaling pathway in the cultured cells dependent upon viral replic
10 TCID50. IBDV-infected cells at the indicated time points post-infection were harvested, who
electrophoresis (SDS-PAGE), transferred to nitrocellulose membranes, and immunoblotted. Th
were analyzed. The amounts of β-actin were also assessed to monitor the equal loadings of p
FACE assay. DF-1 cells were ﬁxed at the indicated time points with 4% formaldehyde and incuba
radish peroxidase (HRP)-conjugated IgG antibodies. JNK1/2 and its phosphorylated formwere
are representative of three independent experiments. Values are shown as the mean±SD fro
(C) Phosphorylated JNK1/2 activates downstream target signal. IBDV-infected cell lysates at th
membranes, and immunoblotted. The protein levels of c-Jun and its phosphorylated form
associatedwith IBDV replication. IBDV-infected cell lysates as well as UV-irradiated IBDV-infect
ylation. p-, phosphorylated.phosphorylation of JNK1/2 was slightly concurrent with expression of
viral capsid protein VP2 in the infected cells (Fig. 1A). In contrast, the
protein levels of total amounts of JNK1/2 do not substantially differ dur-
ing the course of infectionwhen compared to that in themock-infected
cells. To further determine activated JNK quantitatively in the infected
cells, we used a Fast Activated Cell-Based ELISA (FACE) assay (Active
Motif) to investigate the levels of JNK1/2 phosphorylation at the indi-
cated time points after IBDV infection. As shown in Fig. 1B, the kinetics
of phosphorylated JNK1/2 accumulation in the IBDV-infected cells was
consistent with that determined by Western blotting analysis
(Fig. 1A). At 24 h after infection, the activation of phosphorylated JNK
showed approximately 3.5-fold increase than that in themock-infected
cells. Similar patterns of JNK1/2 activation were also observed in Vero
cells following IBDV strain LM infection (data not shown), eliminating
a possible cell line-speciﬁc phenomenon.
Activated JNK performs Ser/Thr phosphorylation of c-Jun inducing
transcription factor. To conﬁrm that phosphorylation of JNK following
IBDV infection truly activated its downstream substrate c-Jun, the
phosphorylation of the transcription factor was measured in the
infected cells by Western blotting. As shown in Fig. 1C, no obvious ac-
tivation of c-Jun was detected in the mock-infected DF-1 cells. Sus-
tained JNK1/2 activation after IBDV infection leads to prolonged
phosphorylation of c-Jun (Fig. 1C), with kinetics that paralleled
those observed for JNK1/2. In contrast, the protein levels of total2.5
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ation. (A)Whole cell lysates fromDF-1 cells after infectionwith IBDV strain LM at aMOI of
le cell lysates were prepared and resolved by sodium dodecyl sulfate-polyacrylamide gel
e protein levels of JNK1/2 and its phosphorylated forms as well as IBDV viral protein VP2
rotein extracts. (B) JNK1/2 activation induced by IBDV infection was determined using a
tedwith antibodies directed against JNK1/2 or its phosphorylated form followed by horse-
each assayed in triplicate. Cell numberswere normalized using crystal violet. These results
m triplicate wells. *, Pb0.05 for a comparison of mock-infected and IBDV-infected cells.
e indicated times were harvested and resolved by SDS-PAGE, transferred to nitrocellulose
were analyzed. β-actin was probed as the loading control. (D) JNK1/2 activation was
ed cell lysates 12 h post-infection were harvested to examine JNK1/2 and c-Jun phosphor-
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fection when compared to that in the mock-infected cells.
We then used an UV light-irradiated IBDV to determine whether
phosphorylation of JNK1/2 was associated with IBDV replication. Cul-
ture ﬂuid from both IBDV-infected DF-1 cells and mock-infected DF-1
cells was collected at 48 h post-infection and exposed to UV light for
20 min. The complete abolition of viral infectivity by UV light treat-
ment was conﬁrmed by titration assay with undiluted viral suspen-
sion (data not shown). In the cells exposed to the UV-irradiated
IBDV (corresponding to a MOI of 10 TCID50), the level of JNK1/2 phos-
phorylation fell to its basal level as seen in that in the mock-infected
cells (Fig. 1D). Also, the cells exposed to the UV-irradiated virus sam-
ple failed to phosphorylate c-Jun (Fig. 1D). Thus, attachment of IBDV
to cell surface receptors alone is not sufﬁcient to induce JNK activa-
tion in the absence of viral replication.
These results demonstrated that activation of JNK1/2 signaling
pathway induced by IBDV infection is possibly through the activation
of its downstream components such as c-Jun, and viral replication is
required for JNK activation.
JNK regulates IBDV replication
To determine whether activated JNK plays any role in the replication
of IBDV, we examined the effect of the kinase on progeny virus produc-
tion in the IBDV-infected DF-1 cells by blocking JNK activation. We
infected DF-1 cells with IBDV in the presence of the JNK inhibitor 1 (5–
20 μM), for inhibition of JNK activation, and determined the virus titers
in the cell culture supernatant at 12 and 24 h postinfection by using a
TCID50 assay. The selected concentrations of the kinase inhibitor were
tested to show its effectiveness in inhibiting virus-induced JNK activity
byWestern blotting, which demonstrated that activation of JNK reduced
dose-dependently (Fig. 2A). For virus production at 12 h postinfection,
the inhibitor resulted in reduction of virus yield (0.25-, and 0.5-log-unit
reduction at 10 and 20 μMcompared to the titer of the no-treatment con-
trol) (Fig. 2B). At 24 h postinfection, treatmentwith the inhibitor at 5, 10,
and 20 μM reduced IBDV progenies by 1.0-, 2.25-, and 3.0-log-unit,A
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Fig. 2. JNK signaling regulates IBDV replication. (A) Inhibition of JNK phosphorylation after tr
infectedwith IBDV in the presence or absence of the JNK inhibitor 1 (5–20 μM). IBDV-infected c
were harvested to examine JNK1/2 and c-Jun phosphorylation. β-actin was used as a protein lo
tants of the IBDV-infected DF-1 cells at 12 and 24 h after treatment with various concentration
determined by TCID50 assay. Values represent the means of three independent experiments. *respectively (Fig. 2B). In addition, the UV-irradiated IBDV failed to grow
comparable to those seen in the mock-infected cells (data not shown).
The result suggested that blockage of JNK activation reduced virus
yield. This shows that optimal IBDV replication requires the JNK activity,
and raises the possibility that IBDVhas acquired the ability to activate the
kinase to aid its replication.
Effect of JNK inhibition on IBDV viral transcription and protein synthesis
To help delineate the mechanism of JNK regulation of IBDV replica-
tion, we further determined which phase of the replication cycle, viral
transcription or protein synthesis, is affected. At ﬁrst, we examined
IBDV viral transcription with RNA extracted from the IBDV-infected
DF-1 cells 24 h after treatment with the JNK inhibitor 1 at 20 μM using
real-time reverse transcription (RT)-PCR analysis. The results revealed
that the abundance of IBDV RNA was signiﬁcantly decreased in the
IBDV-infected cells with the JNK inhibitor 1 treatment (Fig. 3A). At the
indicated time point, the amount of IBDV-speciﬁc RNA in the JNK inhib-
itor-treated cells was approximately 7.5% as compared to that of the
untreated cells. In contrast, similar abundance of the viral RNA was
detected in the DMSO-treated IBDV-infected cells as seen in that in
the IBDV-alone-infected cells (data not shown). No viral RNA accumu-
lation was detected in the UV-irradiated IBDV-infected as well as
mock-infected cells (Fig. 3A).
We then examined the effect of JNK inhibition on viral protein ex-
pression. DF-1 cellswere infectedwith IBDV (MOI of 15) in the presence
or absence of the JNK inhibitor (20 μM), and VP2 protein expression
was monitored by Western blotting. The VP2 protein expression was
substantially reduced when cells were treated with the inhibitor, as
compared to that of the DMSO-treated infected cells (Fig. 3B). No signif-
icant differences were seen in the VP2 protein expression between
DMSO-treated infected cells and untreated infected cells (data not
shown). No VP2 protein expression was detected in the UV-irradiated
VP2-infected as well as mock-infected cells (Fig. 3B and data not
shown). These results suggest that JNK inhibition reduced the accumu-
lation of viral mRNA and protein synthesis.12 h
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Fig. 3. Inhibition of JNK activation decreases viral transcription and protein synthesis in the IBDV-infected DF-1 cells. (A) Effect of JNK inhibitor on IBDV viral mRNA synthesis in
infected cells. Total RNAs isolated from the IBDV-infected cells 24 h after treatment with the JNK inhibitor (20 μM) were subjected to a real-time RT-PCR analysis of VP2 RNA.
Data are normalized to β-actin mRNA and are expressed as percentages of the normalized value for IBDV-infected cells after treatment with the JNK inhibitor over IBDV alone-
infected cells; they are means±SD of values from three independent experiments. *, Pb0.05 for a comparison of IBDV-infected and JNK inhibitor-treated IBDV-infected cells.
(B) Effect of JNK inhibitor on IBDV protein expression. Whole-cell extracts prepared from infected cells 8, 12 and 24 h after treatment with the JNK inhibitor (20 μM) were assayed
by Western blotting for the presence of VP2 expression in the IBDV-infected cells. Equal protein loads were veriﬁed with β-actin blots. p-, phosphorylated.
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IBDVhas been shown to induce apoptosis in the cultured cells via re-
lease of cytochrome c from the mitochondria to the cytosol thereby ac-
tivating caspase-9 followed by caspase-3 pathway (Liu and Vakharia,
2006; Liu et al., 2007). The mitochondrial pathway is regulated by the
Bcl-2 family of proteins, including the pro-apoptotic protein Bax,
which promotes the release of cytochrome c (Kim et al., 2005). Bax re-
sides in the cytoplasm in non-apoptotic cells. In response to apoptotic
stimuli, Bax is activated by a conformational change, resulting in expo-
sure of its NH2 terminus and translocation of the protein to the mito-
chondrial membrane (Lalier et al., 2007).A
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Fig. 4. Bax is activated in IBDV-infected cells. (A) Translocation of the proapoptotic protein
equal amounts of cytosolic and mitochondrial proteins were assayed for Bax by Western blo
ative and positive controls, respectively. Cox II and β-actin were used as protein loading con
mational change in DF-1 cells. (Top) Mock-infected and IBDV-infected DF-1 cells we
immunoprecipitated (IP) with an antibody speciﬁc for active Bax protein (6A7) and the pre
globulin light chains. (Bottom)Whole-cell lysates that were not incubated with antibody we
in samples prior to immunoprecipitation. β-actin was used as protein loading control.We therefore investigated Bax translocation in IBDV-infected DF-1
cells by subcellular fractionation and Western blotting with an anti-
Bax antibody (Fig. 4A). In mock-infected cells, Bax was more abundant
in the cytosol, whereas in staurosporine (STS)-treated (positive con-
trol) and IBDV-infected DF-1 cells, the amount of Bax in the cytosolic
fraction declined with a parallel increase in the membrane fraction.
Thus, Bax was translocated into mitochondria in IBDV-infected DF-1
cells.
To further investigate the conformational change of Bax in virus-
infected cells, total cell lysates were prepared at 12 h postinfection.
Bax was immunoprecipitated with an anti-Bax antibody (6A7) that
speciﬁcally recognizes the active form of Bax protein with an exposedB
IBDV
IP
(6A7) *Activated
Total
Bax
β-actin
Bax to mitochondria in IBDV-infected DF-1 cells. At the indicated times postinfection,
tting. Mock-infected and STS-treated (3 h posttreatment) DF-1 cells were used as neg-
trols for membrane and cytosolic fractions, respectively. (B) IBDV-induced Bax confor-
re lysed in immunoprecipitation buffer. Conformationally active Bax protein was
cipitates were immunoblotted with anti-Bax antibody. The asterisk indicates immuno-
re similarly tested for Bax by immunoblotting to check for equal amounts of Bax protein
160 L. Wei et al. / Virology 420 (2011) 156–163NH2 terminus. Immunoprecipitated Bax from mock- and IBDV-
infected cells was visualized byWestern blotting (Fig. 4B). No obvious
activated Bax was detected in the immunoprecipitates from mock-
infected cells. Active Bax was detected in virus-infected cells as ob-
served in the STS-treated cells used as positive controls. In addition,
the total amount of Bax was not affected in IBDV-infected cells.
These results demonstrate that IBDV infection triggers both Bax
translocation from the cytosol to mitochondria and its conformational
change.
Inhibition of JNK activation prevents Bax-mediated apoptotic responses
in IBDV-infected cells
JNK has been shown to stimulate Bax-dependent, stress-induced re-
lease of cytochrome c (Lei et al., 2002). Therefore, we wished to assess
the role of the JNK signaling pathway in regulating the mitochondrial
pathway of apoptosis in IBDV-infected cells by blocking JNK activation.
We ﬁrst investigated whether JNK activation was required for the
translocation of Bax to mitochondria and the induction of cytochrome
c release in IBDV-infected cells. The speciﬁc JNK inhibitor (20 μM) wasA
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Fig. 5. Inhibition of JNK activation prevents Bax-mediated apoptotic responses in the IBDV-in
JNK inhibitor. DF-1 cells were uninfected or were infected with IBDV in the presence or the
brane fractions were assayed for Bax by Western blotting. Cox II and β-actin were used as
chrome c release is reduced by JNK inhibitor. DF-1 cells were uninfected or were infected
extract proteins were analyzed at 24 h postinfection by immunoblotting with anti-cytochrom
ing. (C) Inhibition of caspase-9 and caspase-3 activities by the JNK inhibitor. DF-1 cells wer
hibitor 1 (20 μM). Whole-cell lysates harvested at 24 h were assayed for LEHDase or DEVD
for caspase-3 (panel b), respectively. Caspase-9 inhibitor LEHD-CHO and caspase-3 inhibi
from three independent experiments. *, Pb0.05 for a comparison of IBDV-infected and JNKadded to cells 1 h before IBDV infection, and was maintained during
the adsorption period and throughout infection, to inhibit JNK activity.
The amount of Bax was unaffected (Fig. 5A), but treatment with the in-
hibitor strongly inhibited Bax translocation from cytosolic fraction to
the membrane fraction in IBDV-infected DF-1 cells (Fig. 5A). Similarly,
the inhibitor strongly inhibited cytochrome c release from the mito-
chondria into the cytosol of IBDV-infected cells but did not affect the
overall abundance of this protein (Fig. 5B). These results show that
IBDV induced JNK activation in the cultured cells is required for Bax
translocation and cytochrome c release.
Released cytochrome c activates caspase-9 in concert with the cyto-
plasmic factors dATP and Apaf-1, as a result, leading consequently to ac-
tivation of caspase-3 (Li et al., 1997). We then determine whether
inhibition of JNK activation inhibits apoptotic caspase activities during
viral infection, DF-1 cells were infected and treated as described
above. Spectroﬂuorometric assays of proteolytic activity were carried
out using synthetic ﬂuorogenic substrates 7-amino-methyl coumarin
(AMC) to measure caspase-9 activity or 7-amino-4-triﬂuoromethyl
coumarin (AFC) tomeasure caspase-3 activity by using BD apoAlert cas-
pase ﬂuorescent assay kits (Clontech). As expected, IBDV alone inducedCytosolic
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fected cells. (A) Inhibition of Bax translocation from the cytosol to mitochondria by the
absence of the JNK inhibitor 1 (20 μM). At 24 h postinfection, the cytosolic and mem-
protein loading controls for membrane and cytosolic fractions, respectively. (B) Cyto-
with IBDV in the presence or the absence of the JNK inhibitor 1 (20 μM). Cytosolic
e c (Cyt c) antibody. β-actin was used as an endogenous control for equal protein load-
e uninfected or were infected with IBDV in the presence or the absence of the JNK in-
ase activity using speciﬁc substrate LEHD-AMC for caspase-9 (panel a) or DEVD-AFC
tor DEVD-CHO were used as internal controls, respectively. Values shown are means
inhibitor-treated IBDV-infected cells.
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activities were signiﬁcantly reduced when the infected cells were trea-
tedwith the JNK inhibitor (Fig. 5C panels a and b). A basal caspase-9 and
caspase-3 activity was detected in the mock-infected cells (Fig. 5C
panels a and b). In addition, inhibitors of caspase-9 and caspase-3 activ-
itywere used as internal controls to conﬁrm assay validity. These results
suggested that the JNK pathway acts upstream of Bax and is involved in
the regulation of IBDV-induced apoptosis. However, this may be an in-
direct effect due to a decrease in virus replication when IBDV-infected
cells were treated with JNK inhibition (Fig. 2B).
Discussion
Infection with a variety of viruses leads to the perturbation of host
cell signaling pathways including the JNK cascade, which can affect
cellular function and virus replication. Here, we demonstrated that
IBDV infection of the cultured cells induced the activation of the JNK
pathway dependent upon viral replication and that inhibition of the
JNK pathway activation leads to a reduction of viral activity, as deter-
mined by decreases in viral transcription, virus protein synthesis and
progeny production. We further demonstrated that IBDV infection-
induced apoptotic responses as evidenced by the activation of the
proapoptotic protein Bax, cytochrome c release, and caspase activa-
tion were blocked when inhibition of the JNK pathway activation in
the IBDV-infected cells. These data suggest that the JNK1/2 signaling
pathway is manipulated by IBDV and that the pathway plays an im-
portant role in viral replication and virus-mediated apoptotic changes
in host cells.
Many viruses utilize the JNK pathway for maximal viral replication
(Diao et al., 2005; Hargett et al., 2005; Holloway and Coulson, 2006;
McLean and Bachenheimer, 1999; Si et al., 2005). In the present
study, we determined whether IBDV-induced JNK activation is in-
volved in viral replication by examining the effect of the JNK inhibitor
on IBDV production and found that inhibition of JNK activation signif-
icantly reduced the production of progeny virus (Fig. 2B). To further
deﬁne at which step virus replication was affected, we found that in-
hibition of the JNK activation suppressed the accumulation of viral-
speciﬁc mRNA and viral protein synthesis in the IBDV-infected cells
(Figs. 3A and B). Thus, the results suggest that inhibition of the JNK
activation reduced the accumulation of viral mRNA and viral protein
synthesis followed by causing a lowered production of infectious
virus particles in the IBDV-infected cells. However, our study does
not rule out the possibility that the speciﬁc inhibitor has a preferen-
tial effect on IBDV viral RNA transcription and/or protein synthesis.
Research data have demonstrated that the JNK pathway modu-
lates the mitochondrial pathways of apoptosis. JNK is required for
the release of proapoptotic molecules such as Bax from the cytosol
to the mitochondria and cytochrome c from the mitochondria to the
cytosol (Lei et al., 2002; Tournier et al., 2000), and thus regulating
cell apoptosis. The regulation of mitochondria-mediated apoptosis
by the JNK pathway has also been documented in reovirus, rotavirus,
poliovirus and inﬂuenza A virus infections (Autret et al., 2007; Clarke
et al., 2004; Martin-Latil et al., 2007). In nonviral apoptotic models,
the JNK signaling pathway has been previously described as a regula-
tor of Bax translocation (Lei et al., 2002) and cytochrome c release
(Tournier et al., 2000). Based on these observations, we investigated
whether the JNK pathway plays a role in regulating IBDV-induced
Bax-mediated apoptotic responses. We ﬁrst demonstrated that IBDV
infection induced Bax activation as evidenced by its conformational
change as well as by its redistribution from the cytosol to mitochon-
dria (Figs. 4A and B) and then demonstrated that the JNK pathway
is required for Bax-mediated apoptotic responses as determined by
blockage of Bax translocation to the mitochondria, cytochrome c re-
lease, as well as caspase-9 and caspase-3 activation by blocking JNK
activation (Figs. 5A, B and C). Bax can be phosphorylated at Thr-167
by the JNK pathway (Kim et al., 2006). Phosphorylation of Bax resultsin a conformational change, exposing its N terminus (activation) and
its C-terminal transmembrane domain, which are required for mito-
chondrial translocation. Therefore, these results suggest that the JNK
signaling pathway plays a role in the mechanism by which IBDV trig-
gers Bax-mediated apoptotic responses in the infected cells.
In conclusion, the results reported here establish that IBDV infec-
tion induces the activation of JNK and its involvement in c-Jun activa-
tion in the cultured cells and demonstrate that the activation of JNK is
required for efﬁcient IBDV replication as well as Bax-mediated apo-
ptotic responses. The role of JNK activation in IBDV replication and
IBDV-mediated apoptotic responses will contribute to important in-
formation about the molecular mechanism of IBDV pathogenesis.
Materials and methods
Virus and cells
A DF-1 chicken embryo ﬁbroblast (CEF) cell line was maintained
in Dulbecco's modiﬁed Eagle medium (DMEM) (GIBCO) supplemen-
ted with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml of
penicillin G, and 100 μl/ml streptomycin at 37 °C in a humidiﬁed 5%
CO2 incubator. The IBDV strain LM (Liu et al., 2002), a CEF cell-
adapted virus, was used in the study. DF-1 cells were infected with
IBDV as previously described (Liu et al., 2007).
Reagents and antibodies
The JNK peptide inhibitor 1 was purchased from Calbiochem (La
Jolla, Calif.). Staurosporine (STS) was obtained from Sigma-Aldrich.
DF-1 cells were treated with either dimethyl sulfoxide (DMSO)
which is the solvent for these two chemicals or their various concen-
trations for 1 h prior to infection. After 1 h of virus adsorption, the
virus inoculum was removed and fresh basal medium containing
fresh chemical was added to the culture. The cytotoxicity of these
two chemicals on DF-1 cells was determined by trypan blue exclusion
dye staining. It was noted that throughout all doses of these two che-
micals used in this study, cell viability assay showed no detectable
cell death in the DF-1 cells.
Rabbit or mouse antibodies against c-Jun, phosphorylated c-Jun
(p-c-Jun), Bax, active Bax (6A7), cytochrome c, Cox II and β-actin
were purchased from Santa Cruz Biotechnology. Antibodies speciﬁc
for JNK and phosphorylated form of JNK (p-JNK) were obtained
from Cell Signaling Technology. Horseradish peroxidase (HRP)-linked
secondary antibodies were purchased from DAKO.
FACE
Fast activated cell-based enzyme-linked immunosorbent assay
(FACE) kit to monitor the levels of JNK1/2 activation was obtained
from Active Motif. Procedure was performed strictly according to
the manufacturer's instructions. Brieﬂy, DF-1 cells seeded in 96-well
plates 1 day were infected with IBDV strain LM and ﬁxed with 4%
formaldehyde in phosphate-buffered saline (PBS) at the indicated
time points after infection. After washing and blocking steps, the
cells were reacted overnight with an anti-JNK1/2 or anti-phospho-
JNK1/2 antibody. Following incubation with a HRP-conjugated sec-
ondary antibody, colorimetric analysis was performed. The A450
was determined using a plate spectrophotometer.
Real-time RT-PCR
Total cell RNAs were prepared from virus-infected DF-1 cells 24 h
after being treated with the JNK inhibitor 1 at 20 μM by using RNeasy
Mini kit (Qiagen) for reverse transcription (RT)-PCR. The protocol of
real-time RT-PCR was carried out as described previously (Wei et al.,
2011).
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The amount of IBDV produced was measured on monolayers of
DF-1 cells. Cell supernatant was serially diluted and inoculated on
monolayers of DF-1 cells. Following 1 h of incubation, fresh DMEM
medium was added and incubated. Three days post-infection, cyto-
pathic effect (CPE) was observed under a microscope and virus titer
was determined as 50% tissue culture infective dose (TCID50) per
0.1 ml.
Whole cell lysates
Whole cell lysate extracts from the DF-1 cells at the indicated time
points after infection or transfection were prepared with the nuclear
extract kit (Active Motif).
Immunoprecipitation
Cell lysates were prepared for immunoprecipitation analysis with
classic IP kit (Pierce) according to the manufacturer's protocol. Brieﬂy,
cells were harvested and washed in PBS and then suspended in IP lysis/
wash buffer and centrifuged for 10 min at 13,000×g. The resulting su-
pernatant was incubated overnight at 4 °C with 10 μg of the anti-Bax an-
tibody (6A7) speciﬁc for the active conformation of Bax and then the
antibody/lysate was added to 20 μl of protein A/G plus agarose in the
spin column. The immunoprecipitates were washed and eluted from
agarose and separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) before Western blotting.
Western blotting
The whole cell lysate extracts prepared were diluted in 2×sample
buffer and boiled for 5 min. Twenty micrograms of each extract was re-
solved on 10–12% SDS-PAGE and blotted onto nitrocellulose (NC)mem-
branes (Stratagene) with a semidry transfer cell (Bio-Rad). The
membraneswere blocked for 2 h at room temperature in blocking buff-
er TBST (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.1% Tween-20) con-
taining 5% skim milk powder to prevent nonspeciﬁc binding, and then
incubated with speciﬁc primary antibodies raised against VP2, JNK1/2,
c-Jun, Bax, active Bax (6A7), cytochrome c, phosphorylated (p)-
JNK1/2, -c-Jun, Cox II, as well as β-actin at room temperature for 2 h.
The membranes were washed three times with TBST buffer, and incu-
bated for 2 h at room temperature with HRP-conjugated secondary an-
tibodies diluted in blocking buffer. Immunoreactive bands were
visualized by enhanced chemiluminescence system (Kodak Image Sta-
tion 4000R).
Fluorimetric assay of caspase activity
Caspase-3 and caspase-9 activities were determined by using BD
apoAlert caspase ﬂuorescent assay kit (Clontech) as described previ-
ously (Liu et al., 2007).
Statistical analysis
Results are presented as averages±the standard deviations or stan-
dard errors of themeans, as indicated. Statistical comparisons are made
by using Student's t test, and differences between groups were consid-
ered signiﬁcant if the P value was b0.05.
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